Register for free to listen to this article
Listen with Speechify
0:00
1:00
Phenomenex Inc.  
 
Phenomenex Inc. has introduced Kinetex, ultra-highperformance LC columns based on the company's new core-shell silica technology.Kinetex meets researchers' need to improve results and increase productivitywithout large capital expenditures. By delivering significant improvements inspeed and separation efficiency over traditional 3- and 5-micron columns,Kinetex enables chromatographers to get performance comparable to sub-2 microncolumns without investing in UHPLC systems. With Kinetex, researchers canachieve UHPLC results on any LC instrument platform, and any chromatographicmethod can now be completed at a fraction of the time previously required,without sacrificing performance. The increased separation efficiencies ofKinetex also significantly reduce solvent usage and maintain long column life.Initially, Kinetex core-shell columns are available in two particle sizes—2.6and 1.7 micron—and three chemistries—C18, PFP and HILIC.   
 
Phenomenex Inc.
www.phenomenex.com
(310) 212-0555

Related Topics

Published In

Loading Next Article...
Loading Next Article...
Subscribe to Newsletter

Subscribe to our eNewsletters

Stay connected with all of the latest from Drug Discovery News.

Subscribe

Sponsored

GreenCooling

Thermo Scientific™ Centrifuges with GreenCool Technology

Next-generation natural refrigerant cooling system for centrifuges, offering a lower Global Warming Potential and reduced energy consumption.
Clear sample tubes are shown in a clear tote with red lids in a sample prep robot with a blue and silver industrial lab background.

The crucial role of sample preparation in biotherapy manufacturing

Discover how better sample preparation can unlock improved assay accuracy and analytical results.
A black mosquito is shown on pink human skin against a blurred green backdrop.

Discovering deeper insights into malaria research

Malaria continues to drive urgent research worldwide, with new therapies and tools emerging to combat the parasite’s complex lifecycle and global burden.
Drug Discovery News March 2025 Issue
Latest IssueVolume 21 • Issue 1 • March 2025

March 2025

March 2025 Issue

Explore this issue